Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by

被引:5
作者
Shah, Arpeet T. [1 ]
Bernardo, Roberto J. [2 ]
Berry, Gerald J. [3 ]
Kudelko, Kristina [2 ]
Wakelee, Heather A. [1 ]
机构
[1] Stanford Univ, Div Oncol, 875 Blake Wilbur Dr,Room 2233, Stanford, CA 94305 USA
[2] Stanford Univ, Div Pulm Allergy & Crit Care, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA
关键词
Communication; Coping strategies; Early palliative care; Lung cancer; Quality of life; TUMOR THROMBOTIC MICROANGIOPATHY; PULMONARY;
D O I
10.1016/j.cllc.2020.09.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients with advanced lung cancer and depressive/anxiety symptoms experience worse quality of life (QoL) We examined whether and how coping strategy influenced QoL in these patients. A multicenter cross-sectional study of 125 patients with advanced lung cancer was conducted. Patients using positive reframing as coping strategy, experience less anxiety and depressive symptoms leading to a better QoL. Introduction: Patients with advanced lung cancer experience high physical symptom burden with substantial psychological distress. Depressive and anxiety symptoms are common and associated with worse quality of life (QoL). Early palliative care (EPC) addresses the complex supportive care needs improving QoL and mood. The mechanisms of EPC are uncertain. We examined whether and how coping strategy, a primary component of EPC, influenced QoL in these patients. Materials and Methods: We conducted a multicenter cross-sectional study of patients with advanced lung cancer. A total of 125 patients completed assessments of QoL (QLQ-C15-PAL), depressive and anxiety symptoms (HADS), and coping (brief COPE questionnaire). The data were analyzed by descriptive statistics. To determine whether and how coping strategy influences QoL, correlations and logistic regressions were performed. Results: Positive reframing correlates significantly with global QoL (r = 0.25, P < .01), emotional well-being (r = 0.33, P < .01), pain (r = -0.30, P < .01), fatigue (r = -0.22, P < .01), loss of appetite (r = -0.22, P < .01) and nausea (r = -0.24, P < .01). Self-blame correlates significantly with worse emotional well-being (r = -0.19, P < .05) and insomnia (r = 0.19, P < .05). Using a 4-step logistic regression model, it was found that anxiety and depressive symptoms fully mediated the relationship between positive reframing and QoL. Conclusions: Patients with advanced lung cancer using positive reframing as coping strategy, experience higher QoL. The mechanism behind it seems that positive reframing goes along with less anxiety and depressive symptoms leading to a better QoL. Self-blame leads to more insomnia and worse emotional well-being. Providing skills to cope effectively could impact QoL in these patients.
引用
收藏
页码:E153 / E156
页数:4
相关论文
共 20 条
  • [1] A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer
    Alexander, Marliese
    Pavlakis, Nick
    John, Thomas
    O'Connell, Rachel
    Kao, Steven
    Hughes, Brett G. M.
    Lee, Adrian
    Hayes, Sarah A.
    Howell, Viive M.
    Clarke, Stephen J.
    Millward, Michael
    Burbury, Kate
    Solomon, Benjamin
    Itchins, Malinda
    [J]. LUNG CANCER, 2020, 142 : 34 - 40
  • [2] Pulmonary tumor embolism
    Bassiri, AG
    Haghighi, B
    Doyle, RL
    Berry, GJ
    Rizk, NW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) : 2089 - 2095
  • [3] ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
    Chiari, Rita
    Ricciuti, Biagio
    Landi, Lorenza
    Morelli, Anna M.
    Delmonte, Angelo
    Spitaleri, Gianluca
    Cortinovis, Diego L.
    Lamberti, Giuseppe
    Facchinetti, Francesco
    Pilotto, Sara
    Verusio, Claudio
    Chella, Antonio
    Bonanno, Laura
    Galetta, Domenico
    Cappuzzo, Federico
    [J]. CLINICAL LUNG CANCER, 2020, 21 (01) : 15 - 20
  • [4] Endicott-Yazdani Tiana, 2015, Proc (Bayl Univ Med Cent), V28, P482
  • [5] Insights on pulmonary tumor thrombotic microangiopathy: a seven-patient case series
    Godbole, Rohit
    Saggar, Rajan
    Zider, Alexander
    Betancourt, Jamie
    Wallace, William D.
    Suh, Robert D.
    Kamangar, Nader
    [J]. PULMONARY CIRCULATION, 2017, 7 (04) : 813 - 820
  • [6] Pulmonary tumor thrombotic microangiopathy: a systematic review
    Godbole, Rohit H.
    Saggar, Rajan
    Kamangar, Nader
    [J]. PULMONARY CIRCULATION, 2019, 9 (02)
  • [7] CLINICAL SUSPICION OF AUTOPSY-PROVEN THROMBOTIC AND TUMOR PULMONARY-EMBOLISM IN CANCER-PATIENTS
    GOLDHABER, SZ
    DRICKER, E
    BURING, JE
    EBERLEIN, K
    GODLESKI, JJ
    MAYER, RJ
    HENNEKENS, CH
    [J]. AMERICAN HEART JOURNAL, 1987, 114 (06) : 1432 - 1435
  • [8] Successful Antemortem Diagnosis and Treatment of Pulmonary Tumor Thrombotic Microangiopathy
    Higo, Kenjuro
    Kubota, Kayoko
    Takeda, Ayano
    Higashi, Michiyo
    Ohishi, Mitsuru
    [J]. INTERNAL MEDICINE, 2014, 53 (22) : 2595 - 2599
  • [9] The diagnostic challenge of pulmonary tumour thrombotic microangiopathy as a presentation for metastatic gastric cancer: a case report and review of the literature
    Ho, Andrew L. K.
    Szulakowsi, Patryk
    Mohamid, Waria H. S.
    [J]. BMC CANCER, 2015, 15
  • [10] Pulmonary tumor thrombotic microangiopathy caused by lung adenocarcinoma: Case report with review of the literature
    Hotta, Machiko
    Ishida, Mitsuaki
    Kojima, Fumiyoshi
    Iwai, Yasuhiro
    Okabe, Hidetoshi
    [J]. ONCOLOGY LETTERS, 2011, 2 (03) : 435 - 437